Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep54: Aoife Brennan 15.10.2019 1:06:05
CEO of Synlogic on developing synthetic biology-based drugs.
Ep53: Phil Sharp 01.10.2019 1:03:59
MIT biologist Phil Sharp on his early career.
Ep52: Bruce Carter 18.09.2019 46:27
Bruce Carter on developing a new tuberculosis drug.
Ep51: Ted Love 03.09.2019 1:02:50
Ted Love of Global Blood Therapeutics on a new drug for sickle cell disease
Ep50: Joel Marcus 20.08.2019 1:04:45
Joel Marcus, chairman of Alexandria Real Estate Equities, on building in biotech clusters.
Ep49: Janelle Anderson 08.08.2019 1:05:07
Janelle Anderson on venture capital and off-the-shelf cell therapy at Century Therapeutics
Ep48: Cindy Perettie 11.07.2019 1:02:25
Cindy Perettie of Foundation Medicine on genomic analysis for cancer.
Ep47: Laura Shawver 02.07.2019 1:10:56
Laura Shawver on synthetic biology engineering of cancer drugs.
Ep46: Liz O'Day 12.06.2019 1:07:02
Liz O'Day on metabolite signatures for predicting cancer drug response.
Ep45: Jay Bradner 22.05.2019 1:11:11
Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.
Ep44: Sheila Gujrathi 09.05.2019 1:12:00
Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer
Ep43: Jeff Jonas 24.04.2019 1:12:19
Sage Therapeutics CEO on psychiatric drug development.
Ep42: Carolyn Bertozzi 09.04.2019 1:09:21
Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.
Ep41: Bob Langer 27.03.2019 1:07:09
MIT's Bob Langer on his journey in science and entrepreneurship.
Ep40: Serge Saxonov 13.03.2019 1:10:12
Serge Saxonov on the single-cell analysis revolution.
Ep39: Julia Owens 26.02.2019 1:09:43
Julia Owens on pivoting, more than once, in a biotech startup.
Ep38: Harlan and Chad Robins (Take 2) 13.02.2019 1:10:26
The co-founders of Adaptive Biotechnologies on immune sequencing.
Ep37: Bonnie Anderson 29.01.2019 1:09:35
Bonnie Anderson of Veracyte on genomic diagnostics.
Ep36: George Scangos 15.01.2019 1:06:40
George Scangos on building an infectious disease company
Ep35: Karen Akinsanya 02.01.2019 1:00:05
Karen Akinsanya of Schrodinger on computational drug discovery
Ep34: Ron Renaud 26.12.2018 1:15:20
Ron Renaud on developing messenger RNA therapies.
Ep33: Krishna Yeshwant 11.12.2018 1:13:06
Krishna Yeshwant of GV on life at the intersection of tech and biotech.
Ep32: Ned David 28.11.2018 1:00:07
Ned David on extending human healthspan.
Ep31: Julie Sunderland 14.11.2018 58:59
Julie Sunderland on VC investing at the nexus of tech and biotech.
Ep30: Barbara Weber 31.10.2018 1:00:02
Barbara Weber on synthetic lethal cancer drug discovery
Similar podcasts
Listen to the The Long Run with Luke Timmerman podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
